Hypomethylation‐activated cancer‐testis gene SPANXC promotes cell metastasis in lung adenocarcinoma-Reference-Cited by-同舟云学术

Hypomethylation‐activated cancer‐testis gene SPANXC promotes cell metastasis in lung adenocarcinoma

Published:2019-09-04 Issue:11 Volume:23 Page:7261-7267
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Wang Xuewei¹,Ju Sihan¹,Chen Yao¹,Qian Qufei¹,Yan Caiwang¹²³,Chen Shuaizhou¹,Chang Yuting¹,Xu Yide¹,Ma Zijian¹²³,Zhang Chang¹²³,Qin Na¹²³,Gu Yayun¹²³,Wang Cheng¹²³⁴,Zhang Erbao¹²³^ORCID,Hu Zhibin¹²³^ORCID

Affiliation:

1. Department of Epidemiology and Biostatistics, Center for Global Health, School of Public Health Nanjing Medical University Nanjing China

2. State Key Laboratory of Reproductive Medicine Nanjing Medical University Nanjing China

3. Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine Nanjing Medical University Nanjing China

4. Department of Bioinformatics, School of Basic Medical Sciences Nanjing Medical University Nanjing China

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14532

Reference34 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Genomic alterations in lung adenocarcinoma

3. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

4. Lung cancer: current therapies and new targeted treatments

5. New and emerging targeted treatments in advanced non-small-cell lung cancer